{"id":"https://openalex.org/W2173600563","doi":null,"title":"Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.","display_name":"Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W2173600563","mag":"2173600563","pmid":"https://pubmed.ncbi.nlm.nih.gov/12161357"},"language":"en","primary_location":{"id":"pmid:12161357","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12161357","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Luigi Zinzani","raw_affiliation_strings":["Istituto di Ematologia e Oncologia Medica L. e A. Ser\u00e0gnoli, Policlinico S.Orsola, via Massarenti 9, 40138 Bologna, Italy. plzinzo@med.unibo.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ematologia e Oncologia Medica L. e A. Ser\u00e0gnoli, Policlinico S.Orsola, via Massarenti 9, 40138 Bologna, Italy. plzinzo@med.unibo.it","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017472528","display_name":"Monica Tani","orcid":"https://orcid.org/0000-0002-5016-2054","observed_orcids":["https://orcid.org/0000-0002-5016-2054"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Tani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111088110","display_name":"Anna Lia Molinari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Lia Molinari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039739851","display_name":"Vittorio Stefoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vittorio Stefoni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012846415","display_name":"Eliana Zuffa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eliana Zuffa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054730003","display_name":"Lapo Alinari","orcid":"https://orcid.org/0000-0002-8870-4162","observed_orcids":["https://orcid.org/0000-0002-8870-4162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lapo Alinari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067576250","display_name":"Annalisa Gabriele","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annalisa Gabriele","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082453515","display_name":"Francesca Bonifazi","orcid":"https://orcid.org/0000-0003-1544-9911","observed_orcids":["https://orcid.org/0000-0003-1544-9911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Bonifazi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009339507","display_name":"Marzia Salvucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marzia Salvucci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112050858","display_name":"Sante Tura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sante Tura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044224344","display_name":"Michele Baccarani","orcid":"https://orcid.org/0000-0003-1999-1687","observed_orcids":["https://orcid.org/0000-0003-1999-1687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele Baccarani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.612,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.92710105,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"87","issue":"8","first_page":"816","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9430000185966492},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.8899999856948853},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8600000143051147},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peripheral-blood-stem-cell-mobilization","display_name":"peripheral blood stem cell mobilization","score":0.8999999761581421},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6000000238418579},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.84516441822052},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.8108106255531311},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.7987245321273804},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7694512605667114},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6313679218292236},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.616290807723999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.600664496421814},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5497956871986389},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.540812075138092},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.46477583050727844},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4285484254360199},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4188171625137329},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4005031883716583},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.22648674249649048}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014182","descriptor_name":"Transplantation, Autologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016026","descriptor_name":"Bone Marrow Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019650","descriptor_name":"Hematopoietic Stem Cell Mobilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:12161357","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12161357","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haematologica","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7c18076462b744f8be51409269349bce","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/7c18076462b744f8be51409269349bce","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematologica, Vol 87, Iss 8 (2002)","raw_type":"article"},{"id":"mag:2173600563","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12161357","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088786267","https://openalex.org/W1992380272","https://openalex.org/W2046415195","https://openalex.org/W2564472276","https://openalex.org/W174073596","https://openalex.org/W1980231382","https://openalex.org/W2473934227","https://openalex.org/W2421969906","https://openalex.org/W2094773778","https://openalex.org/W2144775456"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,52,232],"OBJECTIVES:":[2],"Therapy":[3],"for":[4,48,89],"relapsed/refractory":[5,259],"lymphomas":[6],"should":[7],"be":[8],"based":[9,39],"only":[10],"on":[11,40],"drugs":[12],"not":[13,45,135],"included":[14],"in":[15,112,120,157,173,184,203,214,243,258],"the":[16,22,85,90,113,121,125,140,144,164,177,197,237,240],"front-line":[17,49],"chemotherapy":[18,27],"regimens.":[19],"We":[20],"adopted":[21],"strategy":[23],"of":[24,57,84,92,143,159,191,221,239],"using":[25,36],"salvage":[26],"to":[28,65,151,168],"debulk":[29],"disease":[30,80],"and":[31,42,60,102,110,116,118,225,253],"simultaneously":[32],"mobilize":[33],"stem":[34,95],"cells,":[35],"a":[37,137,188,218,245,251],"regimen":[38,242,257],"ifosfamide":[41],"etoposide,":[43],"(drugs":[44],"usually":[46],"used":[47,64],"treatment).":[50],"DESIGN":[51],"METHODS:":[53],"A":[54],"three-drug":[55],"combination":[56],"ifosfamide,":[58],"epirubicin":[59],"etoposide":[61],"(IEV)":[62],"was":[63,146,155],"treat":[66],"62":[67],"patients":[68,86,127,181,211,260],"with":[69,187,217,261],"relapsing":[70],"or":[71,78,264],"refractory":[72],"aggressive":[73,262],"non-Hodgkin's":[74],"lymphoma":[75],"(NHL;":[76],"n=51)":[77],"Hodgkin's":[79],"(HD;":[81],"n=11).":[82],"Forty-five":[83],"were":[87,172,229],"studied":[88],"feasibility":[91],"peripheral":[93],"blood":[94],"cell":[96],"(PBSC)":[97],"harvest.":[98],"RESULTS:":[99],"The":[100],"overall":[101],"complete":[103],"response":[104,145],"(CR)":[105],"rates":[106],"were,":[107],"respectively,":[108],"77%":[109],"32%":[111],"NHL":[114,263],"subset":[115],"81%":[117],"45%":[119],"HD":[122],"subset.":[123],"Among":[124,163],"17":[126],"who":[128,166],"achieved":[129],"CR":[130,174,186,216],"after":[131,176],"IEV":[132,241,249],"but":[133],"did":[134],"have":[136],"subsequent":[138],"transplantation,":[139],"median":[141,189,219],"duration":[142],"9":[147],"months":[148,193],"(range,":[149,194],"2":[150],"14":[152],"months).":[153],"Mobilization":[154],"successful":[156],"33":[158],"45":[160,165],"(71%)":[161],"patients.":[162],"proceeded":[167],"autotransplantation,":[169],"27":[170],"(60%)":[171],"status":[175],"autograft;":[178],"23/45":[179],"(51%)":[180],"are":[182,212],"currently":[183,213],"continuous":[185,215],"follow-up":[190,220],"25":[192,222],"10-68":[195],"months);":[196],"relapse-free":[198],"survival":[199],"curve":[200],"shows":[201],"83%":[202],"this":[204],"state":[205],"at":[206],"60":[207],"months.":[208,223],"Twenty-three":[209],"(37%)":[210],"Clinical":[224],"hematologic":[226],"toxic":[227],"effects":[228],"mild.":[230],"INTERPRETATION":[231],"CONCLUSIONS:":[233],"Our":[234],"results":[235],"indicate":[236],"efficacy":[238],"inducing":[244],"good":[246],"remission":[247],"rate.":[248],"is":[250],"predictable":[252],"highly":[254],"effective":[255],"mobilization":[256],"HD.":[265]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}